已收盤 05-08 16:00:00 美东时间
-5.010
-4.81%
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
华盛资讯5月8日讯,Epam系统公布2026财年Q1业绩,公司Q1营收14.00亿美元,同比增长7.6%,归母净利润0.83亿美元,同比增长12.3%。
05-08 04:50
EPAM Systems (NYSE:EPAM) is looking for Q2 GAAP EPS of $1.79-$1.87 vs $1.99 analyst estimate..
05-07 18:17
EPAM Systems (NYSE:EPAM) raises FY2026 Adj EPS guidance from $12.60-$12.90 to $12.98-$13.28 vs $12.74 analyst estimate..
05-07 18:15
EPAM Systems (NYSE:EPAM) raises FY2026 GAAP EPS guidance from $7.95-$8.25 to $8.29-$8.59 vs $8.13 analyst estimate..
05-07 18:15
EPAM Sys (NYSE:EPAM) reported quarterly earnings of $2.86 per share which beat the analyst consensus estimate of $2.75 by 4 percent. This is a 18.67 percent increase over earnings of $2.41 per share from the same period
05-07 18:13
今日重点评级关注:Piper Sandler:维持Aclaris Therapeutics"超配"评级,目标价从7美元升至11美元;Evercore ISI集团:维持BioMarin Pharmaceutical"跑赢大市"评级,目标价从110美元升至120美元
05-06 11:29
Delivering measurable business outcomes in production with AI-powered ServiceNow development that improves productivity and reduces total cost of ownership NEWTOWN, Pa., May 5, 2026 /PRNewsw...
05-05 22:02
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
Guggenheim analyst Jonathan Lee maintains EPAM Systems (NYSE:EPAM) with a Buy and lowers the price target from $225 to $200.
05-04 21:12